Beijing Med-Pharm Corporation Expands Its Senior Management Team in China.

PLYMOUTH MEETING, Pa. -- Beijing Med-Pharm Corporation (NASDAQ: BJGP) today announced that it has named pharmaceutical executive Yanping Zhao to the new post of Corporate Vice President.

Serving as the chief representative for Beijing Med-Pharm in China, Mme. Zhao will work with David Gao, CEO of Beijing Med-Pharm, to oversee and coordinate all the Company's Chinese subsidiaries. She will also have responsibility for corporate strategic business development, including mergers and acquisitions, and corporate functions in China.

"We are very pleased to have an executive of Mme. Zhao's caliber join our management team," said Mr. Gao. "With an outstanding track record in operations and business development, she is very well respected in the pharmaceutical industry in China."

"Beijing Med-Pharm has a first-mover advantage in controlling important distribution channels and executing a unique business model that delivers both demand creation and fulfillment," said Mme. Zhao. "This is a new way of structuring a pharmaceutical enterprise in China and I am eager to apply my expertise to continuing its growth in this dynamic market."

Mme. Zhao joins Beijing Med-Pharm from China Biopharmaceutical Limited, a Hong Kong Exchange-listed company, where she served as Vice President, Executive Director and Chief Representative of the Beijing Office. While at China Biopharmaceutical in 2005, Mme. Zhao was instrumental in establishing, developing and selling 55% of Shandong China Tai Freda Pharmaceutical to Bausch & Lomb for $200 million, which at the time was the largest pharmaceutical merger and acquisition ever in China.

She has also held senior management posts at Hainan Tiger Lily Pharmaceutical Co., Ltd., including General Manager and head of Research and Development, Shandong Chia Tai Freda Pharmaceutical Ltd., Xian Chia Tai Pharmaceutical Ltd., Ankang Chia Tai Pharmaceutical Ltd., and Nei Menggu Yuanbaoshan Pharmaceutical Ltd. She began her industry career at the China Nei Mengu Autonomous Region Medicine and Health Products Import & Export Corporation, ultimately serving as Director. Mme. Zhao holds a degree from Shenyang Pharmaceutical University and an MBA from Dalian University of Technology.

About Beijing Med-Pharm Corporation

Beijing Med-Pharm is a pharmaceutical marketing and distribution company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China and pursuing partnerships with other companies seeking to enter the Chinese pharmaceuticals market. Beijing Med-Pharm is the only U.S. public company to offer industry partners a comprehensive suite of market-entry services in China that includes pre-market entry analysis; clinical trial management; product registration; market research; pharmaceutical distribution to hospitals through a unique proprietary network; and pharmaceutical marketing to physicians, hospitals and other healthcare providers.